A new study led by UCLA investigators suggests that chronic stress and an unhealthy diet may work together to fuel the early ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced stages when the disease has already spread, or metastasized. About half of ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following surgery in a small, early trial were still alive, most without disease ...

The biotech company Dynamic42, a specialist in organ-on-chip technology, has made a significant advance in pancreatic cancer ...

A Community Education Council meeting in Manhattan was disrupted by around 100 trans rights activists through silent dancing and heckling to oppose policies on transgender athletes. This ongoing ...

Professor Teusch and Dynamic42 set out their work in one of the most challenging cancers, with PDAC being the most common and lethal form of pancreatic cancer. A major cause of it ...

Advances in stem cell biology and immune cell engineering bring diabetes cell therapies closer to reality. I n 2024, a woman ...

Dr. Flavio Rocha is part of a team of OHSU surgeons who are making surgery an option for more pancreatic cancer patients than ever. Pancreatic cancer starts when cells grow out of control in the ...

Microscope image of mouse pancreatic tissue, with insulin-producing tissue marked in brown. Early-life exposure to a specific gut microbe appears to boost growth of insulin-producing tissue, the new ...